The first lawsuit against Bayer AG and Janssen involving the drug Xarelto has started in a state court. Most products liability cases involving dangerous or defective drugs are filed in federal district courts. These cases can however, be filed in state courts across the county so long as jurisdiction is…
Xarelto is a member of a class of blood thinners known as new oral anticoagulants. It was primarily developed by German pharmaceutical giant Bayer AG as a drug that could compete with Warfarin (Coumadin) that has been the gold standard of blood thinners for many years. Bayer partnered with a…
Xaretlto and its competitors were manufactured and marketed as anticoagulant medications that were a one-dose-fits-all solution. This defectively designed medication with insufficient warnings turned out be a very dangerous option for many patients and turned out not to be that perfect one-dose solution it was heralded to be for those…
Xarelto is a member of a class of drugs known as New Oral Anticoagulants (NOACs). This class of drugs also includes several competitors to Xaretlo, including Eliquis, Pradaxa, and Savaysa, which is the newest class member. These medications are approved by the U.S. Food and Drug Administration (FDA), to treat…
There is no question that millions of Americans are in need of potentially life-saving medications to prevent strokes from occurring. In fact, as discussed in a recent Bio Pharma Dive article, strokes are up in the U.S. The conventional treatment for strokes for decades was Warfarin (Coumadin), which is a…
According to a recent news article from the Madison St. Clair Record, a plaintiff has just filed a products liability lawsuit against the makers of Xarelto, Bayer Pharmaceuticals and Janssen Research and Development. Janssen Research and Development was formerly known as Johnson and Johnson Pharmaceuticals Research and is still a…
Last year, the United States Food and Drug Administration (FDA) became aware that a device used to monitor a patient’s blood in Xarelto clinical trials had problems. Now it has been reported by British Medical Journal, and via FiercePharma, that the two major drug companies (Janssen/Johnson & Johnson and Bayer…
For many years, if someone needed a blood thinner, he or she would take Warfarin (Coumadin). This product is relatively safe and there are not many side effects, so long as a person carefully monitors his or her diet and has regular blood tests so their doctor can check the…
The makes of Xarelto (Bayer and Johnson & Johnson) took a major hit this week in terms of the future of there flagship drug. Xarelto is a member of a relatively new class of drugs called New Oral Anticoagulants (NOACs). NOACs are used for patients who suffer from a series…
There is no question that Xarelto has been linked to a lot of serious bleeding disorders, many of which resulted in death. There are many reasons the drug has proven so dangerous to users, but a lot of the problems are result of the reportedly negligent manner in which Bayer…